{
    "2018-02-26": [
        [
            {
                "time": "2018-01-02",
                "original_text": "How Tax Reform Affected Medtronic's 3Q18 Performance",
                "features": {
                    "keywords": [
                        "Tax Reform",
                        "Medtronic",
                        "3Q18",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Medtronic Recovers from 1H18 Disasters with Robust 3Q18 Sales",
                "features": {
                    "keywords": [
                        "Medtronic",
                        "Recovery",
                        "1H18",
                        "Disasters",
                        "Robust",
                        "3Q18",
                        "Sales"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "What Analysts Recommend for Medtronic, Post-3Q18 Results",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommend",
                        "Medtronic",
                        "Post-3Q18",
                        "Results"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "George Soros Just Bought These 2 Biotech Stocks. Should You?",
                "features": {
                    "keywords": [
                        "George Soros",
                        "Bought",
                        "Biotech",
                        "Stocks"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}